Report From the Second Global Scientific Conference on Clinical Trial Design and Outcome Measures for <i>RDH12</i>-Associated Inherited Retinal Degeneration
A multi-stakeholder, patient centric approach will be critical to the design of future successful clinical trials with outcome measures relevant to the RDH12-IRD population.
Authors
- Tomás S. Alemán (ORCID: https://orcid.org/0000-0001-5709-0236)
- Mathew T. Pletcher
- Bart P. Leroy (ORCID: https://orcid.org/0000-0002-9899-2081)
- Sue Lacey
- Todd A. Durham (ORCID: https://orcid.org/0000-0002-0363-0329)
- Silvia Cerolini (ORCID: https://orcid.org/0000-0001-5625-0357)
- Jean Bennett (ORCID: https://orcid.org/0000-0003-3378-8263)
- Courtney Coates
Institutions
- Penn Presbyterian Medical Center (US)
- Ghent University Hospital (BE)
- Foundation Fighting Blindness (US)
- Micro Focus (United States) (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1167/tvst.13.8.17
- Citations
- 1
- Primary Topic
- Retinal Development and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.23